These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 27733957

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Medication persistence in Turkish children and adolescents with attention-deficit/hyperactivity disorder.
    Ayaz M, Ayaz AB, Soylu N, Yüksel S.
    J Child Adolesc Psychopharmacol; 2014 Oct; 24(8):442-7. PubMed ID: 25010598
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Overlapping Prescriptions of Stimulants for Children and Adolescents With Attention-Deficit Hyperactivity Disorder.
    Chen CY, Yeh HH, Fang SY, Wu EC, Chang IS, Lin KM.
    Psychiatr Serv; 2012 Oct; 63(10):1011-8. PubMed ID: 22911441
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Diagnostic clusters associated with an early onset schizophrenia diagnosis among children and adolescents.
    Jerrell JM, McIntyre RS, Deroche CB.
    Hum Psychopharmacol; 2017 Mar; 32(2):. PubMed ID: 28370311
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Attention Deficit/Hyperactivity Disorder and Global Severity Profiles in Treatment-Seeking Patients with Substance Use Disorders.
    Icick R, Moggi F, Slobodin O, Dom G, Mathys F, van den Brink W, Levin FR, Blankers M, Kaye S, Demetrovics Z, van de Glind G, Velez-Pastrana MC, Schellekens ASA, ICASA-group.
    Eur Addict Res; 2020 Mar; 26(4-5):201-210. PubMed ID: 32570249
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
    Bussing R, Narwaney KJ, Winterstein AG, Newton DA, DeBar L, Boscarino JA, Toh S, Pawloski P, Nordin JD, Herrinton LJ, Mason D, Daley MF.
    Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
    [Abstract] [Full Text] [Related]

  • 33. [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder].
    Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens ASA, van de Glind G, Banaschewski T, Barta C, Begeman A, Casas M, Crunelle CL, Daigre Blanco C, Dalsgaard S, Demetrovics Z, den Boer J, Dom G, Eapen V, Faraone SV, Franck J, González RA, Grau-López L, Groenman AP, Hemphälä M, Icick R, Johnson B, Kaess M, Kapitány-Fövény M, Kasinathan JG, Kaye SS, Kiefer F, Konstenius M, Levin FR, Luderer M, Martinotti G, Matthys FIA, Meszaros G, Moggi F, Munasur-Naidoo AP, Post M, Rabinovitz S, Ramos-Quiroga JA, Sala R, Shafi A, Slobodin O, Staal WG, Thomasius R, Truter I, van Kernebeek MW, Velez-Pastrana MC, Vollstädt-Klein S, Vorspan F, Young JT, Yule A, van den Brink W, Hendriks V.
    Z Kinder Jugendpsychiatr Psychother; 2021 Jan; 50(1):54-67. PubMed ID: 34397296
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Differences in Utilization Patterns among Medications in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: a 36-Month Retrospective Study Using the Korean Health Insurance Review and Assessment Claims Database.
    Bhang SY, Hwang JW, Kwak YS, Joung YS, Lee S, Kim B, Sohn SH, Chung US, Yang J, Hong M, Bahn GH, Choi HY, Oh IH, Lee YJ.
    J Korean Med Sci; 2016 Aug; 31(8):1284-91. PubMed ID: 27478341
    [Abstract] [Full Text] [Related]

  • 37. Injury prevention by medication among children with attention-deficit/hyperactivity disorder: a case-only study.
    Mikolajczyk R, Horn J, Schmedt N, Langner I, Lindemann C, Garbe E.
    JAMA Pediatr; 2015 Apr; 169(4):391-5. PubMed ID: 25686215
    [Abstract] [Full Text] [Related]

  • 38. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
    Kollins SH.
    Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
    [Abstract] [Full Text] [Related]

  • 39. ADHD Medication and Substance-Related Problems.
    Quinn PD, Chang Z, Hur K, Gibbons RD, Lahey BB, Rickert ME, Sjölander A, Lichtenstein P, Larsson H, D'Onofrio BM.
    Am J Psychiatry; 2017 Sep 01; 174(9):877-885. PubMed ID: 28659039
    [Abstract] [Full Text] [Related]

  • 40. Polypharmacy in children and adolescents treated for major depressive disorder: a claims database study.
    McIntyre RS, Jerrell JM.
    J Clin Psychiatry; 2009 Feb 01; 70(2):240-6. PubMed ID: 19192465
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.